Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$337.92M+5.0%$298.58M-19.1%$301.71M-18.2%$319.59M-7.5%$321.82M-3.3%
$135.21M+21.8%$127.98M+14.4%$120.9M+7.3%$115.14M+2.0%$110.97M-0.5%
-$2.71M-24.6%-$2.75M-17.4%-$2.38M+12.9%-$1.01M+84.0%-$2.18M+55.0%
-$39.59M-212%-$2.35M+12.6%-$2.83M$6.99M$35.42M
$18K-$38K
$20.13M-83.8%$125.16M+443%$129.74M+539%$136.03M+838%$124.63M+271%
$6.73M-$2.47M-$6.4M
$344.89M-19.1%$280.47M-42.2%$292.56M-36.4%$313.39M-28.0%$426.22M+3.5%
$68.42M+24.0%$78.82M+60.9%$83.46M+72.7%$69.36M+39.8%$55.15M+25.5%
$11.54M+116%-$19.36M+61.0%-$65.15M+24.2%
$282.35M-6.1%$259.25M-21.4%$259.92M-20.3%$257.01M-17.7%$300.76M-2.4%
-$348.8M+5.0%-$325.7M+17.8%-$326.37M+16.9%-$323.46M+14.6%-$367.2M+2.0%
-$29.42M-548%-$6.14M+87.4%
-$2.71M-24.6%-$2.75M-17.4%-$2.38M+12.9%-$1.01M+84.0%-$2.18M+55.0%
$6.73M-$2.47M-$6.4M
$20.68M+244%-$22.46M-121%
$18K-$38K
$78K-74.1%$11K-94.0%$76K$194K$301K
$40M-52.4%
$90M+200%$120M$120M$90M+800%$30M-28.6%
$66.46M0.0%$66.45M0.0%$66.45M0.0%$66.44M0.0%$66.44M0.0%
$160M-26.9%$173.5M-20.8%$191M-12.0%$206M-5.8%$219M-2.3%
$160M-26.9%$173.5M-20.8%$191M-12.0%$206M-5.8%$219M-2.3%
$291.78M-21.4%$216.96M-50.2%$224.41M-45.5%$259.35M-32.7%$371.06M+0.9%
$291.78M-21.4%$216.96M-50.2%$224.41M-45.5%$259.35M-32.7%$371.06M+0.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Westlake Chemical Partners generate?
Westlake Chemical Partners (WLKP) generated $344.9M in operating cash flow over the trailing twelve months.
What is Westlake Chemical Partners's free cash flow?
After $68.4M of capital expenditures, Westlake Chemical Partners's free cash flow was $291.8M over the trailing twelve months, down 21.4% year over year.
Where does Westlake Chemical Partners's cash flow data come from?
Every line is extracted from Westlake Chemical Partners's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.